779 related articles for article (PubMed ID: 17197923)
1. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
2. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
[TBL] [Abstract][Full Text] [Related]
5. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
Tvrdík D; Povýsil C; Svatosová J; Dundr P
Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
[TBL] [Abstract][Full Text] [Related]
8. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
9. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
Wei Y; Wang J; Zhu X; Shi D; Hisaoka M; Hashimoto H
Chin Med J (Engl); 2002 Jul; 115(7):1043-7. PubMed ID: 12150740
[TBL] [Abstract][Full Text] [Related]
10. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M
Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935
[TBL] [Abstract][Full Text] [Related]
12. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
Inagaki H; Nagasaka T; Otsuka T; Sugiura E; Nakashima N; Eimoto T
Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
[TBL] [Abstract][Full Text] [Related]
13. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma.
Sun Y; Sun B; Wang J; Cai W; Zhao X; Zhang S; Hao X
Cancer Sci; 2009 Jun; 100(6):1018-25. PubMed ID: 19385976
[TBL] [Abstract][Full Text] [Related]
15. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
[TBL] [Abstract][Full Text] [Related]
16. SYT-SSX fusion genes in synovial sarcoma of the thorax.
Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
[TBL] [Abstract][Full Text] [Related]
17. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
[TBL] [Abstract][Full Text] [Related]
18. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Iwasaki H; Sonobe H; Goto H; Kusakabe H; Takahira T; Kobayashi C; Kawaguchi K; Saito T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2006 Jun; 19(6):820-31. PubMed ID: 16557275
[TBL] [Abstract][Full Text] [Related]
20. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
Tsuji S; Hisaoka M; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M; Nakamura T
Am J Pathol; 1998 Dec; 153(6):1807-12. PubMed ID: 9846971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
